.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Express Scripts
Medtronic
Covington
Harvard Business School
Fish and Richardson
Accenture
Farmers Insurance
Federal Trade Commission

Generated: September 24, 2017

DrugPatentWatch Database Preview

Hydroxypropyl cellulose - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydroxypropyl cellulose and what is the scope of hydroxypropyl cellulose patent protection?

Hydroxypropyl cellulose
is the generic ingredient in one branded drug marketed by Aton and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for hydroxypropyl cellulose. One supplier is listed for this compound.

Summary for Generic Name: hydroxypropyl cellulose

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list40
Suppliers / Packagers: see list1
Clinical Trials: see list70
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydroxypropyl cellulose at DailyMed

Pharmacology for Ingredient: hydroxypropyl cellulose

Drug ClassDemulcent
Mechanism of ActionDemulcent Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
LACRISERT
hydroxypropyl cellulose
INSERT;OPHTHALMIC018771-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Citi
QuintilesIMS
Express Scripts
Chubb
McKinsey
Cantor Fitzgerald
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot